Karyopharm Therapeutics KPTI Earnings Call Transcripts

NASDAQ KPTI
$0.02 -0.02 (-56.50%)
At close: Nov 10, 2026 · 4:00 PM EST
26 earnings calls on file for Karyopharm Therapeutics, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Karyopharm Therapeutics Q2 2026 Earnings Call

Aug 13, 2026 5,857 words · 25 min read
  • Brendan StrongSenior Vice President, Investor Relations
  • Richard PaulsonPresident and Chief Executive Officer
  • Reshma RangwalaChief Medical Officer
  • Sohanya ChengChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Karyopharm Therapeutics Earnings Call Transcripts

Calls26
LatestAug 13, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 26 Karyopharm Therapeutics transcripts Register to get access to Karyopharm Therapeutics’s earnings call transcripts.